List of works - Oliver Distler

2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.

scientific article

2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative

scientific article

Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator-Initiated, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial

scientific article published on 10 December 2019

Analysis of vascular gene expression in arthritic synovium by laser-mediated microdissection.

scientific article

Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers

scientific article

COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD

scientific article published on 02 April 2020

Distinct expression of adhesion molecules on skin fibroblasts from patients with diffuse and limited systemic sclerosis. A pilot study

scientific article

Effects of rituximab in connective tissue disorders related interstitial lung disease

scientific article published in September 2016

Elevated serum levels of sonic hedgehog are associated with fibrotic and vascular manifestations in systemic sclerosis.

scientific article published on 11 May 2017

European multicentre study validates enhanced liver fibrosis test as biomarker of fibrosis in systemic sclerosis

scientific article published on 01 February 2019

Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis

scientific article

Expression of interleukin-21 receptor, but not interleukin-21, in synovial fibroblasts and synovial macrophages of patients with rheumatoid arthritis

scientific article

Fibroblast growth factor receptor 3 activates a network of profibrotic signaling pathways to promote fibrosis in systemic sclerosis

scientific article published on 01 September 2020

Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR group.

scientific article published on 11 May 2017

Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension

scientific article published on 09 December 2019

Heart non-specific effector CD4+ T cells protect from postinflammatory fibrosis and cardiac dysfunction in experimental autoimmune myocarditis

scientific article published on 20 December 2019

Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort

scientific article published on 22 September 2020

Incidence and risk factors for gangrene in patients with systemic sclerosis from the EUSTAR cohort

scientific article published on 2 December 2019

Involvement of the myeloid cell compartment in fibrogenesis and systemic sclerosis

scientific article published on 01 May 2019

Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise

scientific article published on March 2012

Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs)

scientific article published on 09 October 2020

Microparticles as regulators of inflammation: novel players of cellular crosstalk in the rheumatic diseases

scientific article

Might Nailfold Capillaroscopy Be a "Proxy" for Lung Involvement in Connective Tissue Diseases?

scientific article published on 01 September 2019

Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease

scientific article published on 20 May 2019

Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study

scientific article published on 09 April 2019

Platelet-derived serotonin links vascular disease and tissue fibrosis

scientific article

Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis

scientific article published on 21 June 2019

Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis

scientific article published on 12 August 2013

Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database

scientific article published on 28 September 2020

Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort

scientific article

Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension

scientific article

Regulation of Fibroblast Apoptosis and Proliferation by MicroRNA-125b in Systemic Sclerosis

scientific article published on 01 November 2019

Response to: ' Correspondence on 'Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension'' by Iudici <i>et al</i>

scientific article published on 16 December 2020

Response to: 'Correspondence on 'Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial'' by Bredemeier

scientific article published on 06 October 2020

Response to: 'Riociguat in systemic sclerosis: a potential for disease modification' by Jain and Dhir

scientific article published on 15 July 2020

Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrual

scientific article published on 17 August 2019

Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial

scientific article published on 01 May 2020

Safety and effectiveness of abatacept in systemic sclerosis: The EUSTAR experience

scientific article published on 03 February 2020

Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial

scientific article published on 05 August 2020

Serum Biomarkers for Connective Tissue and Basement Membrane Remodeling are Associated with Vertebral Endplate Bone Marrow Lesions as Seen on MRI (Modic Changes)

scientific article published on 27 May 2020

Significant weight loss in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

scientific article published on 25 March 2020

Stiff skin syndrome: evidence for an inflammation-independent fibrosis?

scientific article published on 25 May 2009

Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management

scientific article published on 29 April 2020

The challenge of Very Early Systemic Sclerosis: a Combination of Mild and Early Disease?

scientific article published on 15 March 2020

The induction of matrix metalloproteinase and cytokine expression in synovial fibroblasts stimulated with immune cell microparticles

scientific article

The molecular control of angiogenesis

scientific article

The role of membrane lipids in the induction of macrophage apoptosis by microparticles

scientific article

Tie2 as a novel key factor of microangiopathy in systemic sclerosis.

scientific article

Transforming growth factor-β-dependent Wnt secretion controls myofibroblast formation and myocardial fibrosis progression in experimental autoimmune myocarditis.

scientific article published on 20 April 2016

Update of EULAR recommendations for the treatment of systemic sclerosis

scientific article published on 9 November 2016

Validation of the suction device Nimble for the assessment of skin fibrosis in systemic sclerosis

scientific article published on 03 June 2020

Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR population

scientific article published on 17 January 2015

Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis

scientific article published on January 2007

Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the DeSScipher inception cohort study

scientific article published on 07 August 2019

List of works by Oliver Distler

2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.

2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative

Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator-Initiated, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial

Analysis of vascular gene expression in arthritic synovium by laser-mediated microdissection.

Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers

COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD

Distinct expression of adhesion molecules on skin fibroblasts from patients with diffuse and limited systemic sclerosis. A pilot study

Effects of rituximab in connective tissue disorders related interstitial lung disease

Elevated serum levels of sonic hedgehog are associated with fibrotic and vascular manifestations in systemic sclerosis.

European multicentre study validates enhanced liver fibrosis test as biomarker of fibrosis in systemic sclerosis

Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis

Expression of interleukin-21 receptor, but not interleukin-21, in synovial fibroblasts and synovial macrophages of patients with rheumatoid arthritis

Fibroblast growth factor receptor 3 activates a network of profibrotic signaling pathways to promote fibrosis in systemic sclerosis

Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR group.

Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension

Heart non-specific effector CD4+ T cells protect from postinflammatory fibrosis and cardiac dysfunction in experimental autoimmune myocarditis

Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort

Incidence and risk factors for gangrene in patients with systemic sclerosis from the EUSTAR cohort

Involvement of the myeloid cell compartment in fibrogenesis and systemic sclerosis

Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise

Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs)

Microparticles as regulators of inflammation: novel players of cellular crosstalk in the rheumatic diseases

Might Nailfold Capillaroscopy Be a "Proxy" for Lung Involvement in Connective Tissue Diseases?

Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease

Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study

Platelet-derived serotonin links vascular disease and tissue fibrosis

Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis

Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis

Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database

Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort

Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension

Regulation of Fibroblast Apoptosis and Proliferation by MicroRNA-125b in Systemic Sclerosis

Response to: ' Correspondence on 'Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension'' by Iudici <i>et al</i>

Response to: 'Correspondence on 'Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial'' by Bredemeier

Response to: 'Riociguat in systemic sclerosis: a potential for disease modification' by Jain and Dhir

Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrual

Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial

Safety and effectiveness of abatacept in systemic sclerosis: The EUSTAR experience

Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial

Serum Biomarkers for Connective Tissue and Basement Membrane Remodeling are Associated with Vertebral Endplate Bone Marrow Lesions as Seen on MRI (Modic Changes)

Significant weight loss in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

Stiff skin syndrome: evidence for an inflammation-independent fibrosis?

Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management

The challenge of Very Early Systemic Sclerosis: a Combination of Mild and Early Disease?

The induction of matrix metalloproteinase and cytokine expression in synovial fibroblasts stimulated with immune cell microparticles

The molecular control of angiogenesis

The role of membrane lipids in the induction of macrophage apoptosis by microparticles

Tie2 as a novel key factor of microangiopathy in systemic sclerosis.

Transforming growth factor-β-dependent Wnt secretion controls myofibroblast formation and myocardial fibrosis progression in experimental autoimmune myocarditis.

Update of EULAR recommendations for the treatment of systemic sclerosis

Validation of the suction device Nimble for the assessment of skin fibrosis in systemic sclerosis

Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR population

Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis

Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the DeSScipher inception cohort study